Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | NPY1R | P25929 | 1/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7371174 | 0.92 | ALDH1A1 (0.68) | ALDH1A1NPY1RNPY5RPOLBLMNA | |
| SCHEMBL7973186 | 0.88 | ALDH1A1 (0.90) | ALDH1A1NPY1RNPY5RTBXA2R | |
| SCHEMBL11626883 | 0.87 | ALDH1A1 (0.67) | ALDH1A1NPY1RNPY5RTBXA2RLMNA | |
| SCHEMBL6792727 | 0.84 | ALDH1A1 (1.00) | ALDH1A1NPY1RNPY5RTBXA2RLMNA | |
| SCHEMBL1928807 | 0.84 | CYP1A2 (0.67) | ALDH1A1NPY1RNPY5RPOLBLMNA | |
| SCHEMBL9927436 | 0.83 | ALDH1A1 (0.68) | ALDH1A1NPY1RNPY5RPOLB | |
| Hydrochloric Acid SCHEMBL1846589 | 0.83 | CYP1A2 (0.66) | ALDH1A1NPY1RNPY5RPOLB | |
| SCHEMBL6791530 | 0.82 | ALDH1A1 (0.68) | ALDH1A1NPY1RNPY5RPOLBLMNA | |
| SCHEMBL6848743 | 0.82 | KAT6A (0.63) | ALDH1A1POLB | |
| SCHEMBL22467259 | 0.82 | ALDH1A1 (0.77) | ALDH1A1TBXA2RLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | OY JUVANTIA PHARMA LTD. (FI) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | SSTR4, SSTR1, SSTR3 | ALDH1A1 4124/4885NPY1R 7/4885NPY5R 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.